Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens

Amplification of the human epidermal growth factor receptor 2 (HER2) is a prognostic marker for poor clinical outcome and a predictive marker for therapeutic response to targeted therapies in breast cancer patients. With the introduction of anti-HER2 therapies, accurate assessment of HER2 status has...

Descripción completa

Detalles Bibliográficos
Autores principales: Furrer, Daniela, Jacob, Simon, Caron, Chantal, Sanschagrin, François, Provencher, Louise, Diorio, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584735/
https://www.ncbi.nlm.nih.gov/pubmed/23379971
http://dx.doi.org/10.1186/1746-1596-8-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584735/
https://www.ncbi.nlm.nih.gov/pubmed/23379971
http://dx.doi.org/10.1186/1746-1596-8-17

Ejemplares similares